Leituras sugeridas

 

Seção 1 - Desenvolvimento Normal e Anormal

American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV-

TR). Text revision, 4th ed. Washington, DC: American Psychiatric Association; 2000.

Lord, C., Bishop, S. L. Autism spectrum disorders: diagnosis, prevalence and services for children

and families. Social Policy Report. 2010; 24:1–21.

Park, T. S., Ghatan, S., Scott, R. M. Pediatrics. In: Winn, H.R., eds. Youmans neurological surgery, 2.

Philadelphia: Elsevier; 2011:1861–2358.

Scarpinato, N., Bradley, J., Kurbjun, K., Bateman, X., Holtzer, B., Ely, B. Caring for the child with

an autism spectrum disorder in the acute care setting. J Spec Pediatr Nurs. 2010; 15:244–254.

Strock M. Autism spectrum disorders (pervasive developmental disorders). NIH publication no. NIH-

04-5511. Bethesda, MD: National Institute of Mental Health, National Institutes of Health, U.S. Department of Health and Human Services; 2004. Available at

http://www.nimh.nih.gov/health/publications/autism/nimhautismspectrum.pdf.

 

Seção 2 - Distúrbios Neurocognitivos e do Córtex Cerebral

Bonelli, R. M., Cummings, J. L. Frontal-subcortical dementias. Neurologist. 2008; 14:100–107.

Burns J.M., Morris J.C., eds. Early diagnosis and treatment of mild cognitive impairment. Hoboken,

NJ: Wiley Press, 2008.

Burns, J. M., Swerdlow, R. H. Right orbitofrontal tumor presenting as pedophilia symptom and

constructional apraxia sign. Arch Neurol. 2003; 60:437–440.

Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S. Classification of primary progressive aphasia and

its variants. Neurology. 2011; 76:1006–1014.

Kandel, E. R. The biology of memory: a forty-year retrospective. J Neurosci. 2009; 294:12748–

12756.

McKeel, D. W., Burns, J. M., Meuser, T. M., Morris, J. C. Dementia: an atlas of investigation and

diagnosis. Oxford, England: Clinical Publishing; 2007.

Mesulam M.M., ed. Principles of behavioral and cognitive neurology. New York: Oxford University

Press, 2000.

Swerdlow, R. H., Anderson, H., Burns, J. M. Alzheimer's disease. In: Kreutzer J.S., DeLuca J.,

Caplan B., eds. Encyclopedia of clinical neuropsychology. New York: Springer; 2011:105–110.

 

Seção 3 - Epilepsia

Berg, A. T., Berkovic, S. F., Brodie, M. J., Buchhalter, J., Cross, J. H., Van Emde, B. W., et al.

Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE

Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010; 51:676–685.

Berkovic, S. F. Epilepsy: insights into causes and treatment dilemmas. Lancet Neurol. 2010; 9:9–11.

Engel, J., Jr. A practical guide for routine EEG studies in epilepsy. J Clin Neurophysiol. 1984; 1:109–

142.

Gorji, A., Speckmann, E. J. Epileptiform EEG spikes and their functional significance. Clin EEG

Neurosci. 2009; 40:230–233.

Kossoff, E. H., Zupec-Kania, B. A., Amark, P. E., Ballaban-Gil, K. R., Christina Bergqvist, A. G.,

Blackford, R., et al. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia. 2009; 50:304–317.

McNamara, J. O. Cellular and molecular basis of epilepsy. J Neurosci. 1994; 14:3413–3425.

Neville, B. G., Chin, R. F., Scott, R. C. Childhood convulsive status epilepticus: epidemiology,

management and outcome. Acta Neurol Scand Suppl. 2007; 186:21–24.

Obeid, M., Wyllie, E., Rahi, A. C., Mikati, M. A. Approach to pediatric epilepsy surgery: state of the

art, part I: general principles and presurgical workup. Eur J Paediatr Neurol. 2009; 13:102–114.

Obeid, M., Wyllie, E., Rahi, A. C., Mikati, M. A. Approach to pediatric epilepsy surgery: state of the

art, part II: approach to specific epilepsy syndromes and etiologies. Eur J Paediatr Neurol. 2009; 13:115–127.

Pitkanen, A., Lukasiuk, K. Mechanisms of epileptogenesis and potential treatment targets. Lancet

Neurol. 2011; 10:173–186.

Rogawski, M. A., Loscher, W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci. 2004;

5:553–564.

Scharfman, H. E. The neurobiology of epilepsy. Curr Neurol Neurosci Rep. 2007; 7:348–354.

Shewmon, D. A. What is a neonatal seizure? Problems in definition and quantification for

investigative and clinical purposes. J Clin Neurophysiol. 1990; 7:315–368.

Shields, W. D. Catastrophic epilepsy in childhood. Epilepsia. 2000; 41(Suppl 2):S2–S6.

Shorvon S., ed. Status epilepticus: its clinical features and treatment in children and adults.

Cambridge: Cambridge University Press, 2006.

Spencer, S., Huh, L. Outcomes of epilepsy surgery in adults and children. Lancet Neurol. 2008;

7:525–537.

Spreafico, R., Blumcke, I. Focal cortical dysplasias: clinical implication of neuropathological

classification systems. Acta Neuropathol. 2010; 120:359–367.

Stockler-Ipsiroglu, S., Plecko, B. Metabolic epilepsies: approaches to a diagnostic challenge. Can J

Neurol Sci. 2009; 36(Suppl 2):S67–S72.

Wiebe, S., Blume, W. T., Girvin, J. P., Eliasziw, M. A randomized, controlled trial of surgery for

temporal-lobe epilepsy. N Engl J Med. 2001; 345:311–318.

Wyllie E., Cascino G.D., Gidal B.E., Goodkin H.P., eds. Wyllie's treatment of epilepsy: principles

and practice. Lippincott Williams & Wilkins: Philadelphia, 2010:1–1040.

 

Seção 4 - Psiquiatria

American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM IV-

TR), 4th ed. Washington, DC: American Psychiatric Association; 2000.

Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., Walters, E. E. Lifetime

prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62:593–602.

Wittchen, H. U., Jacobi, F. Size and burden of mental disorders in Europe: a critical review and

appraisal of 27 studies. Eur Neuropsychopharmacol. 2005; 15:357–376.

Depressão/Transtorno Bipolar

Barnett, J. H., Smoller, J. W. The genetics of bipolar disorder. Neuroscience. 2009; 164:331–343. Cerullo, M. A., Adler, C. M., Delbello, M. P., Strakowski, S. M. The functional neuroanatomy of

bipolar disorder. Int Rev Psychiatry. 2009; 21:314–322.

Merikangas, K. R., Jin, R., He, J. P., Kessler, R. C., Lee, S., Sampson, N. A., et al. Prevalence and

correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011; 68:241–251.

Ansiedade/Pânico/Transtorno de Estresse Pós-Traumático

Roberts, A. L., Gilman, S. E., Breslau, J., Breslau, N., Koenen, K. C. Race/ethnic differences in

exposure to traumatic events, development of post-traumatic stress disorder, and treatment-seeking for post-traumatic stress disorder in the United States. Psychol Med. 2011; 41:71–83.

Stein, M. B. Neurobiology of generalized anxiety disorder. J Clin Psychiatry. 2009; 70(Suppl 2):15–

19.

Stein, M. B., Stein, D. J. Social anxiety disorder. Lancet. 2008; 371:1115–1125.

Transtorno Obsessivo-Compulsivo

Dantzer, R., O’Connor, J. C., Freund, G. G., Johnson, R. W., Kelley, K. W. From inflammation to

sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008; 9:46–56.

Jenike, M. A. Clinical practice. Obsessive-compulsive disorder. N Engl J Med. 2004; 350:259–265.

Ruscio, A. M., Stein, D. J., Chiu, W. T., Kessler, R. C. The epidemiology of obsessive-compulsive

disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010; 15:53–63. [Epub Aug 26, 2008].

Somatização

Browning, M., Fletcher, P., Sharpe, M. Can neuroimaging help us to understand and classify

somatoform disorders? A systematic and critical review. Psychosom Med. 2011; 73:173–184.

Lempert, T., Brandt, T., Dieterich, M., Huppert, D. How to identify psychogenic disorders of stance

and gait: a video study in 37 are not enough. Can J Psychiatry. 2008; 53:213–223.

Levenson, J. The somatoform disorders: 6 characters in search of an author. Psychiatr Clin North

Am. 2011; 34:515–524.

Owens, C., Dein, S. Conversion disorder: the modern hysteria. Adv Psychiatr Treat. 2006; 12:152–

157.

Schroder, A., Fink, P. Functional somatic syndromes and somatoform disorders in special

psychosomatic units: organizational aspects and evidence-based treatment. Psychiatr Clin North Am. 2011; 34:673–687.

Toth, C. Hemisensory syndrome is associated with a low diagnostic yield and a nearly uniform

benign prognosis. J Neurol Neurosurg Psychiatry. 2003; 74:1113–1116.

Transtorno Conversivo Kanaan, R., Armstrong, D., Barnes, P., Wessely, S. In the psychiatrist's chair: how neurologists

understand conversion disorder. Brain. 2009; 132(Pt 10):2889–2896.

Ruddy, R., House, A. Psychosocial interventions for conversion disorder. Cochrane Database Syst

Rev. (4):2005. [CD005331].

Esquizofrenia

Brown, A. S., Derkits, E. J. Prenatal infection and schizophrenia: a review of epidemiologic and

translational studies. Am J Psychiatry. 2010; 167:261–280.

Dutta, R., Murray, R.M., Hotopf, M., Allardyce, J., Jones, P.B., Boydell, J. Arch Gen Psychiatry.

2010; 67:1230–1237.

Foussias, G., Remington, G. Negative symptoms in schizophrenia: avolition and Occam's razor.

Schizophr Bull. 2010; 36:359–369.

Howes, O. D., Kapur, S. The dopamine hypothesis of schizophrenia: version III—the final common

pathway. Schizophrenia Bull. 2009; 35:549–562.

Addiction

Amato L, Minozzi S, Davoli M. Efficacy and safety of pharmacological interventions for the

treatment of the alcohol withdrawal syndrome. Cochrane Database Syst Rev 2011;(6):CD008537.

Connery HS, editor. Harvard Medical School Special Health Report. Alcohol use and abuse, 2011.

Available at http://www.health.harvard.edu.

Connery, H. S., McHugh, K., Greenfield, S. F. How well does AA work? That's (partly) up to you.

Current Psychiatry. 2005; 4:1–6.

Dodrill, C. L., Helmer, D. A., Kosten, T. R. Prescription pain medication dependence. Am J

Psychiatry. 2011; 168:466–471.

Kleber, H. D., Weiss, R. D., Anton, R. F., Jr., George, T. P., Greenfield, S. F., Kosten, T. R., et al.

Work Group on Substance Use Disorders; American Psychiatric Association; Steering Committee on Practice Guidelines. Treatment of patients with substance use disorders, second edition. Am J Psychiatry. 2007; 164(Suppl 4):5–123.

Truco, E. M., Connery, H. S., Griffin, M. L., Greenfield, S. F. The relationship of self esteem and

self-efficacy to treatment outcomes of alcohol dependent men and women. Am J Addict. 2007; 16:85–92.

Woody, G. E., Poole, S. A., Subramaniam, G., Dugosh, K., Bogenschutz, M., Abbott, P., et al.

Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA. 2008; 300:2003–2011.

Transtorno da Personalidade Borderline

Lieb, K., Vollm, B., Rucker, G., Timmer, A., Stoffers, J. M. Pharmacotherapy for borderline

personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry. 2010; 196:4–12.

Paris, J. The treatment of borderline personality disorder: Implications of research on diagnosis,

etiology, and outcome. Annu Rev Clin Psychol. 2009; 5:277–290.

Abuso do Parceiro Íntimo

Burnett LB, Adler J. Domestic violence. 2011. Available at

http://www.emedicine.medscape.com/article/805546. Accessed November 21, 2011.

Breiding, M. J., Black, M. C., Ryan, G. W. Chronic disease and health risk behaviors associated with

intimate partner violence—18 U.S. states/territories, 2005. Ann Epidemiol. 2008; 18:538–544. Campbell, J. C., Jones, A. S., Dienemann, J., Kub, J., Schollenberger, J., O’Campo, P., et al. Intimate

partner violence and physical health consequences. Arch Intern Med. 2002; 162:1157–1163.

Center for Disease Contol and Prevention Injury Center. Violence prevention. Intimate partner

violence. Available at

http://www.cdc.gov/ViolencePrevention/intimatepartnerviolence/index.html.

National Center on Elder Abuse. 2011. Available at

http://www.ncea.aoa.gov/ncearoot/Main_Site/index.aspx.

Sellas MI, Krouse LH. Elder Abuse. 2011. Available at

http://emedicine.medscape.com/article/805727.

Transtorno Cerebral Orgânico

Wandinger, K. P., Saschenbrecker, S., Stoecker, W., Dalmau, J. Anti-NMDA-receptor encephalitis: a

severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol. 2011; 231:86– 91. [Epub Oct 15, 2010].

Pediatria Transtornos

American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and

treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007; 46:1503–1526.

American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and

treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2007; 46:267–283.

American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and

treatment of children and adolescents with oppositional defiant disorder. J Am Acad of Child Adolesc Psychiatry. 2007; 46:126–141.

American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and

treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007; 46:894–921.

Denton, J., Newton, A.W., Vandeven, A.M. Update on child maltreatment: toward refining the

evidence base. 2011; 23:240–248.

Joseph-DiCaprio, J. Counseling parents of difficult adolescents. Minn Med. 2010; 93:41–43. Rosen, D. S. American Academy of Pediatrics Committee on Adolescence. Identification and

management of eating disorders in children and adolescents. Pediatrics. 2010; 126:1240–1253.

 

Seção 5 - Hipotálamo, Hipófise, Sono e Tálamo

Barion, A., Zee, P. C. A clinical approach to circadian rhythm sleep disorders [review]. Sleep Med.

2007; 8:566–577.

Burstein, R. Somatosensory and visceral input to the hypothalamus and limbic system. Prog Brain

Res. 1996; 107:257–267.

Fontes, M. A., Xavier, C. H., de Menezes, R. C., Dimicco, J. A. The dorsomedial hypothalamus and

the central pathways involved in the cardiovascular response to emotional stress. Neuroscience. 2011; 184:64–74. [Epub Mar 22, 2011].

Gautron, L., Elmquist, J. K. Sixteen years and counting: an update on leptin in energy balance. J Clin

Invest. 2011; 121:2087–2093.

Monti J.M., Pandi-Perumal S.R., Sinton C.M., eds. Neurochemistry of sleep and wakefulness.

Cambridge: Cambridge University Press, 2008.

Morrison, S. F., Nakamura, K. Central neural pathways for thermoregulation. Front Biosci. 2011;

16:74–104.

Nakamura, K. Central circuitries for body temperature regulation and fever. Am J Physiol Regul

Integr Comp Physiol. 2011; 301:R1207–R1228.

Nunn, N., Womack, M., Dart, C., Barrett-Jolley, R. Function and pharmacology of spinally-

projecting sympathetic pre-autonomic neurones in the paraventricular nucleus of the hypothalamus. Curr Neuropharmacol. 2011; 9:262–277.

Saper, C. B. The central autonomic nervous system: conscious visceral perception and autonomic

pattern generation. Annu Rev Neurosci. 2002; 25:433–469. [Epub Mar 25, 2002].

Saper, C. B. Staying awake for dinner: hypothalamic integration of sleep, feeding, and circadian

rhythms. Prog Brain Res. 2006; 153:243–252.

Saper, C. B. The hypothalamus. In: Mai J.K., Paxinos G., eds. The human nervous system. 3rd ed.

Amsterdam: Academic Press; 2012:548–573.

Saper, C. B., Chou, T. C., Elmquist, J. K. The need to feed: homeostatic and hedonic control of

eating. Neuron. 2002; 36:199–211.

Saper, C. B., Scammell, T. E., Lu, J. Hypothalamic regulation of sleep and circadian rhythms. Nature.

2005; 437:1257–1263.

Scammell, T. E. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol. 2003;

53:154–166.

Vianna, C. R., Coppari, R. A treasure trove of hypothalamic neurocircuitries governing body weight

homeostasis. Endocrinology. 2011; 152:11–18.

Wise, M. S., Arand, D. L., Auger, R. R., Brooks, S. N., Watson, N. F. American Academy of Sleep

Medicine. Treatment of narcolepsy and other hypersomnias of central origin [review]. Sleep. 2007; 30:1712–1727.

 

Seção 6 - Distúrbios da Consciência (Coma)

Booth, C. M., Boone, R. H., Tomlinson, G., Detsky, A. S. Is this patient dead, vegetative, or severely

neurologically impaired? Assessing outcome for comatose survivors of cardiac arrest. JAMA. 2004; 291:870–879.

Bruno, M. A., Vanhaudenhuyse, A., Thibaut, A., Moonen, G., Laureys, S. From unresponsive

wakefulness to minimally conscious PLUS and functional locked-in syndromes: recent advances in our understanding of disorders of consciousness. J Neurol. 2011; 258:1373–1384.

Jennett, B. The persistent vegetative state: task force's definition influences interpretation of outcome

[comment]. BMJ. 1995; 310:1137.

Laureys, S. The neural correlate of (un)awareness: lessons from the vegetative state. Trends Cogn

Sci. 2005; 9:556–559.

Medical aspects of the persistent vegetative state (1). The Multi-Society Task Force on PVS. N Engl

J Med 1994;330:1499-508.

Nakagawa, T. A., Ashwal, S., Mathur, M., Mysore, M. Clinical report: guidelines for the

determination of brain death in infants and children: an update of the 1987 task force recommendations. Pediatrics. 2011; 128:e720–e740.

Neumar, R. W., Nolan, J. P., Adrie, C., Aibiki, M., Berg, R. A., Böttiger, B. W., et al. Post-cardiac

arrest syndrome: epidemiology, pathophysiology, treatment and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation. 2008; 118:2452–2483.

Overgaard, M. How can we know if patients in coma, vegetative state or minimal conscious state are

conscious? Prog Brain Res. 2009; 177:11–19.

Posner, J. B., Saper, C. B., Schiff, N. D., Plum, F. Plum and Posner's diagnosis of stupor and coma,

4th ed. Oxford, England: Oxford University Press; 2007.

Teasdale, G., Jennett, B. Assessment of coma and impaired consciousness: a practical scale. Lancet.

1974; 2:81–84.

Wijdicks, E. F., Bamlet, W. R., Maramattom, B. V., Manno, E. M., McClelland, R. L. Validation of a

new coma scale: the four score. Ann Neurol. 2005; 58:585–593.

Wijdicks, E. F.M. The comatose patient. Oxford, England: Oxford University Press; 2008.

Wijdicks, E. F.M., Varelas, P. N., Gronseth, G. S., Greer, D. M. Evidence-based guideline update:

determining brain death in adults. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010; 74:1911–1918.

Young, G. B., Ropper, A. H., Bolton, C. F. Coma and impaired consciousness: a clinical perspective.

Philadelphia: McGraw-Hill; 1998.

 

Seção 7 - Núcleos da Base e Transtornos do Movimento

 

Parkinsonism

Adams R., Victor M., eds. Principles of neurology, 4th ed., New York: McGraw-Hill, 1977.

Galvez-Jimenez N., ed. Scientific basis for the treatment of Parkinson's disease, 2nd ed., London:

Taylor and Francis, 2005.

Galvez-Jimenez N., Tuite P., eds. Unusual causes of movement disorders. New York: Cambridge

University Press, 2011.

Jankovic J., Tolosa E., eds. Parkinson's disease and movement disorders, 5th ed., Philadelphia:

Lippincott Williams & Wilkins, 2007.

Stern G., ed. Parkinson's disease. Baltimore: Johns Hopkins University Press, 1990.

Tarsy D., Vitek J., Lozano L.M., eds. Surgical treatment of Parkinson's disease and other movement

disorders. New York: Humana Press, 2003.

Distonia

Bressman, S. B., de Leon, D., Kramer, P. L., Ozelius, L. J., Brin, M. F., Greene, P. E., et al. Dystonia

in Ashkenazi Jews: clinical characterization of a founder mutation [published erratum appears in Ann Neurol 1995;37:140]. Ann Neurol. 1994; 36:771–777.

Brin M.F., Comella C., Jankovic J., eds. Dystonia: etiology, clinical features, and treatment.

Philadelphia: Lippincott Williams & Wilkins, 2004.

Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group. A prevalence study of

primary dystonia in eight European countries. J Neurol Neurosurg Psychiatry 2000; 247:787–792.

Tarsy, D., Simon, D. K. Dystonia. N Engl J Med. 2006; 355:818–829.

Coreia/Balismo

Walker, F. O. Huntington's disease. Lancet. 2007; 369:218–228. Walker R., ed. The differential diagnosis of chorea. New York: Oxford University Press, 2011.

Zomorrodi, A., Wald, E. R. Sydenham's chorea in western Pennsylvania. Pediatrics. 2006; 117:e675–

e679.

Tremor

Fahn S., Jankovic J., Hallett M., eds. Principles and practice of movement disorders, 2nd ed., St

Louis: Elsevier Saunders, 2011.

Koller, W. C., Busenbark, K., Miner, K. The relationship of essential tremor to other movement

disorders: report on 678 patients. Essential Tremor Study Group. Ann Neurol. 1994; 35:717–723.

Lemon, R. N., Edgley, S. A. Life without a cerebellum. Brain. 2010; 133(Pt 3):652–654.

Tiques e Síndrome de Tourette

Cohen, D.J., Jankovik, J., Goetz, C.G., eds. Tourette syndrome. Advances in Neurology; 85.

Lippincott Williams & Wilkins, Philadelphia, 2001.

Lees A.J., ed. Tics and related disorders. Edinburgh: Churchill Livingstone, 1985.

Singer H., Mink J.W., Gilbert D.L., Jankovik J., eds. Movement disorders in childhood. Philadelphia:

Saunders Elsevier, 2010.

Mioclonias

Fahn S., Jankovic J., Hallett M., eds. Principles and practice of movement disorders, 2nd ed., St

Louis: Elsevier Saunders, 2011.

Galvez-Jimenez N., Tuite P., eds. Unusual causes of movement disorders. New York: Cambridge

University Press, 2011.

Koenig, M. A., Geocadin, R. Global hypoxia-ischemia and critical care seizures. In: Varelas P., ed.

Seizures in critical care: a guide to diagnosis and therapeutics: current clinical neurology. 2nd ed. New York: Humana Press; 2010:157–178.

Lance, J. W., Adams, R. D. The syndrome of intention or action myoclonus as a sequel to hypoxic

encephalopathy. Brain. 1963; 86:111–136.

Doença de Wilson

El-Youssef, M. Wilson disease. Mayo Clin Proc. 2003; 78:1126–1136.

Liebeskind, D. S., Wong, S., Hamilton, R. H. Faces of the giant panda and her cub: MRI correlates of

Wilson's disease. J Neurol Neurosurg Psychiatry. 2003; 74:682.

Paralisia Encefálica

Ashwal, S., Russman, B. S., Blasco, P. A., Miller, G., Sandler, A., Shevell, M., et al. Practice

parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2004; 62:851–863.

Mutch, L., Alberman, E., Hagberg, B., Kodama, K., Perat, M. V. Cerebral palsy epidemiology: where

are we now and where are we going? Dev Med Child Neurol. 1992; 34:547–551. Seção 8 - Cerebelo e Ataxia

Anheim, M., Tranchant, C., Koenig, M. The autosomal recessive cerebellar ataxias. N Engl J Med.

2012; 366(7):636–646.

Boltshauser E., Schmahmann J.D., eds. Cerebellar disorders in children. Clinics in Developmental

Medicine No. 191-2. London: MacKeith Press, 2012.

Brice, A., Pulst, S.M., eds. Spinocerebellar degenerations: the ataxias and spastic paraplegias: Blue

Books of Neurology Series; 31. Butterworth-Heinemann, 2007.

Buckner, R. L., Krienen, F. M., Castellanos, A., Diaz, J. C., Yeo, B. T. The organization of the human

cerebellum estimated by intrinsic functional connectivity. J Neurophysiol. 2011; 106(5):2322– 2345.

De Zeeuw CI, Cicirata F, editors. Creating coordination in the cerebellum. Prog Brain Res, Volume

148, Amsterdam: Elsevier; 2005.

Durr, A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet

Neurol. 2010; 9(9):885–894.

Highsteen SM, Thach WT, editors. The cerebellum: recent developments in cerebellar research. Ann

NY Acad Sci 2002;978:1–551.

Ito, M. The cerebellum and neural control. New York: Raven Press; 1984.

Leiner, H. C., Leiner, A. L., Dow, R. S. Does the cerebellum contribute to mental skills? Behav

Neurosci. 1986; 100(4):443–454.

Manto M.U., Gruol D., Schmahmann J.D., Koibuchi N., Rossi F., eds. Handbook of the cerebellum

and cerebellar disorders. New York: Springer, 2012.

Manto, M. Cerebellar Disorders: A practical approach to diagnosis and management. Cambridge:

Cambridge University Press; 2010.

Schmahmann, J. D. An emerging concept: The cerebellar contribution to higher function. Arch

Neurol. 1991; 48:1178–1187.

Schmahmann JD, editor. The cerebellum and cognition. Int Rev Neurobiol Volume 47. San Diego:

Academic Press. 1997.

Schmahmann, J. D. Disorders of the cerebellum. Ataxia, dysmetria of thought, and the cerebellar

cognitive affective syndrome. J Neuropsychiatry Clin Neurosci. 2004; 16(3):367–378.

Schmahmann, J. D. The role of the cerebellum in cognition and emotion: personal reflections since

1982 on the dysmetria of thought hypothesis, and its historical evolution from theory to therapy. Neuropsychol Rev. 2010; 20(3):236–260.

Schmahmann, J. D., Doyon, J., Toga, A., Petrides, M., Evans, A. MRI Atlas of the human cerebellum.

San Diego: Academic Press; 2000.

Schmahmann JD, Pandya DN. The cerebrocerebellar system. In : Schmahmann, J.D., editor. The

Cerebellum and Cognition. San Diego: Academic Press. Int Rev Neurobiol 1997;41:31-60.

Schmahmann, J. D., Pandya, D. N. Anatomic organization of the basilar pontine projections from

prefrontal cortices in rhesus monkey. J Neurosci. 1997; 17:438–458.

Schmahmann, J. D., Sherman, J. C. The cerebellar cognitive affective syndrome. Brain. 1998;

121:561–579.

Stoodley, C. J., Valera, E. M., Schmahmann, J. D. Functional topography of the cerebellum for motor

and cognitive tasks: an fMRI study. NeuroImage. 2012; 59(2):1560–1570. Strick, P. L., Dum, R. P., Fiez, J. A. Cerebellum and nonmotor function. Annu Rev Neurosci. 2009;

32:413–434.

Voogd, J., Glickstein, M. The anatomy of the cerebellum. Trends Neurosci. 1998; 21(9):370–375. Voogd, J. Cerebellar zones: a personal history. Cerebellum. 2011; 10(3):334–350.

 

Seção 9 - Circulação Cerebrovascular e AVE

Bederson, J. B., Connolly, E. S., Jr., Batjer, H. H., Dacey, R. G., Dion, J. E., Diringer, M. N., et al.

Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group the Stroke Council of the American Heart Assocaition. Stroke. 2009; 40:994–1025.

Berkefeld, J., Chaturvedi, S. The International Carotid Stenting Study and the North American

Carotid Revascularization Endarterectomy versus Stenting Trial: fueling the debate about carotid artery stenting. Stroke. 2010; 41:2714–2715.

Caplan L.R., ed. Posterior circulation disease: clinical findings, diagnosis, and management. Boston:

Blackwell Scientific, 1996.

Caplan L.R., ed. Caplan's stroke: a clinical approach, 4th ed., Philadelphia: Saunders, 2009.

Caplan L.R., Van Gyn J., eds. Stroke syndromes, 3rd ed., Cambridge: Cambridge University Press,

2012.

Chaves, C. J., Lee, G. Imaging findings in carotid artery dissection. In: Schaller B., ed. Imaging of

carotid stenosis. Stockholm: Karolinska Institute, 2007.

Edlow, J. A., Caplan, L. R. Avoiding pitfalls in the diagnosis of subarachnoid hemorrhage. N Engl J

Med. 2000; 342:29–36.

Frieden, I. J., Reese, V., Cohen, D. PHACE syndrome. The association of posterior fossa brain

malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol. 1996; 132:307–311.

Fullerton, H. J., Aminoff, A. R., Ferriero, D. M., Gupta, N., Dowd, C. F. Neurodevelopmental

outcome after endovascular treatment of vein of Galen malformations. Neurology. 2003; 61:1386–1390.

Furie, K. L., Kasner, S. E., Adams, R. J., Albers, G. W., Bush, R. L., et al. Guidelines for the

prevention of stroke in patients with strokes or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42:227–276.

Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., et al.

Guidelines for the primary prevention of stroke: a guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42:517–584.

Scott, R. M., Smith, J. L., Roberston, R. L., Madsen, J. R., Soriano, S. J., Rockoff, M. A. Long-term

outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg. 2004; 100(Suppl 2 Pediatrics):142–149.

Suarez, J. I., Tarr, R. W., Selman, W. R. Aneurysmal subarachnoid hemorrhage. N Engl J Med. 2006;

354:387–396.

 

Seção 10 - Esclerose Múltipla e Outros Transtornos

Autoimunes do Sistema Nervoso Central

Esclerose Múltipla

Batista, F. D., Harwood, N. E. The who, how and where of antigen presentation to B cells. Nat Rev

Immunol. 2009; 9:15–27.

Brinkman, V. FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the

central nervous system. Br J Pharmacol. 2009; 158:1173–1182.

Crotty, S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol. 2011; 29:621–663. Dalla Libera, D., Di Mitri, D., Bergami, A., Centonze, D., Gasperini, C., Grasso, M. G., et al. T

regulatory cells are markers of disease activity in multiple sclerosis patients. PLoS ONE. 2011; 6:e21386.

Davis, M. D., Kehrl, J. H. The influence of sphingosine-1-phophate receptor signaling on lymphocyte

trafficking: how a bioactive lipid mediator grew up from an “immature” vascular maturation factor to a “mature”mediator of lymphocyte behavior and function. Immunol Res. 2009; 43:187– 197.

Dhib-Jalbut, S., Marks, S. Interferon-β mechanisms of action in multiple sclerosis. Neurology. 2010;

74(Suppl 1):S17–S24.

Fabriek, B. O., Zwemmer, J. N.P., Teunissen, C. E., Dikstra, C. D., Pohlman, C. H., Laman, J. D., et

al. In vivo detection of myelin proteins in cervical lymph nodes of MS patients using ultra-sound guided fine-needle aspiration cytology. J Neuroimmunol. 2005; 161:190–194.

Fainardi, E., Rizzo, R., Melchiorri, L., Stignani, M., Castellazzi, C., Tamborino, E., et al. CSF levels

of soluble HLA-G and Fas molecules are inversely associated to MRI evidnce of disease activity in patients with relapsing remitting multiple sclerosis. Mult Scler. 2008; 14:446–454.

Feng, X., Reder, N. P., Yanamandala, M., Hill, A., Franek, B. S., Niewold, T. B., et al. Type I

interferon is high in lupus and neuromyelitis optica but low in multiple sclerosis. J Neurol Sci. 2012; 313:48–53. [Epub Oct 27, 2011].

Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Scmidbauer, M., et al.

The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009; 13:1175–1189.

International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2,

Sawcer, S., Hellenthal, G., Pirinen, M., Spencer, C. C., et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011; 476:214–219.

Gay, D., Esiri, M. Blood-brain barrier damage in acute multiple sclerosis plaques. Brain. 1991;

114:557–572.

Gold R, Kappos L, Arnold D, et al. Oral BG-12 in relapsing-remitting multiple sclerosis: results from

the randomomized, placebo-controlled, phase 3 DEFINE study. Submitted, 2012.

Goodin, D. S., Arnason, B. G., Coyle, P. K., Frohman, E. M., Paty, D. W. The use of mitoxantrone

(Novantrone) for the treatment of multiple sclerosis. Neurology. 2003; 61:1332–1338.

Hartung, H. P., Freedman, M. S., Polman, C. H., Edan, G., Kappos, L., Miller, D. H., et al. Interferon

beta-1β-neutralizing antibodies 5 years after clinically isolated syndrome. Neurology. 2011; 77:835–843.

Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., et al. B-cell depletion

with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med. 2008; 358:676–688.

Howell, O. W., Rundle, J. L., Garg, A., Komada, M., Brophy, P. J., Reynolds, R., et al. Activated

microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis. J Neuropathol Exp Neurol. 2010; 69:1017–1033.

Kappos, L., Li, D., Calabresi, P. A., O’Connor, P., Bar-Or, A., Barkhof, F., et al. Ocrelizumab in

relapsing-remitting multiple sclerosis: a phase 2, randomoized, placebo-controlled, multicenter trial. Lancet. 2011; 378:1779–1787.

Katakai, T., Hara, T., Lee, J.-H., Gonda, H., Sugai, M., Shimizu, A. A novel reticular stromal

structure in lymph node cortex: an immuno-platform for interactions among dendritic cells, T cells and B cells. Int Immunol. 2004; 16:1133–1142.

Kim, H. J., Miron, V. E., Dukala, D., Proia, R. L., Ludwin, S. K., Traka, M., et al. Neurobiological

effects of sphingosine 1-phosphate receptor modulation in the cuprizone model. FASEB J. 2011; 25:1509–1518.

Kitano, M., Moriyama, S., Ando, Y., Hikida, M., Mori, Y., Kurosaki, T., et al. Bcl6 protein

expression shapes pre-germinal center B cell dynamics and follicular helper T cell heterogeneity. Immunity. 2011; 34:961–972.

Kivisakk, P., Imitola, J., Rasmussen, S., Elyaman, W., Zhu, B., Ransohoff, R. M., et al. Localizing

central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Ann Neurol. 2008; 65:457–469.

Kooi, E.-J., van Horssen, J., Witte, M. E., Amor, S., Bø, L., Dijkstra, C. D., et al. Abundant

extracellular myelin in the meninges of patients with multiple sclerosis. Neuropathol Appl Neurobiol. 2009; 35:283–295.

Linker, R. A., Lee, D.-H., Demir, S., Wiese, S., Kruse, N., Siglienti, I., et al. Functional role of brain-

derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. Brain. 2010; 133:2248–2263.

Magliozzi, R., Howell, O., Vora, A., Serafini, B., Nicholas, R., Puopolo, M., et al. Meningeal B-cell

follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain. 2007; 130:1089–1104.

Moore, G. R.W., Esiri, M. M. The pathology of multiple sclerosis and related disorders. Diagnostic

Histopathol. 2011; 17:225–231.

Munger, K. L., Levin, L. I., O’Reilly, E. J., Falk, K. I. A. Anti-Epstein-Barr virus antibodies as

serological markers of multiple sclerosis: a prospective study among United States military personnel. MS J. 2011; 17:1185–1193.

Murphy, K. M., Stockinger, B. Effector T cell plasticity: flexibility in the face of changing

circumstances. Nat Immunol. 2010; 11:674–680.

Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., et al. Diagnostic

criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011; 69:292–302.

Prodinger, C., Bunse, J., Kruger, M., Schiefenhövel, F., Brandt, C., Laman, J. D., et al. CD11c-

expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system. Acta Neuropathol. 2011; 121:445–458.

Racke, M. K., Lovett-Racke, A. E., Karandikar, N. J. The mechanism of action of glatiramer acetate

in multiple sclerosis. Neurology. 2010; 74(Suppl 1):S25–S30.

Schreiber, R. D., Old, L. J., Smyth, M. J. Cancer immunoediting: integrating immunity's roles in

cancer suppression and promotion. Science. 2011; 331:1565–1570.

Smolders, J., Damoiseaux, J., Menheere, P., Hupperts, R. Vitamin D as an immune modulator in

multiple sclerosis: a review. J Neuroimmunol. 2008; 194:7–17.

Tennakoon, D. K., Mehta, R. S., Ortega, S. B., Bhoj, V., Racke, M. K., Karandikar, N. J., et al.

Therapeutic induction of regulatory, cytotoxic, CD8+ T cells in multiple sclerosis. J Immunol. 2006; 176:7119–7129.

Verhey, L. H., Branson, H. M., Shroff, M. M., Callen, D. J., Sled, J. G., Narayanan, S., et al. CNS:

MRI parameters for prediction of multiple sclerosis diagnosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol. 2011; 10:1065–1073.

Weller, R. O., Galea, I., Carare, R. O., Minagar, A. Pathophysiology of the lymphatic drainage of the

central nervous system: implications for pathogensis and therapy of multiple sclerosis. Pathophysiology. 2010; 17:295–306.

Wheeler, D., Venkata, V., Bandaru, R., Calabresi, P. A., Nath, A., Haughey, N. J., et al. A defect of

sphingolipid metabolism modifies the proerties of normal appearing white matter in multiple sclerosis. Brain. 2008; 131:3092–3102.

Zhou, L., Chong, M. M.W., Littman, D. R. Plasticity of CD4+ T cell lineage differentiation.

Immunity. 2011; 30:646–655.

Encefalomielite Disseminada Aguda (EMDA)

Gutrecht, J. A., Berger, J. R., Jones, H. R., Mancall, A. C. Monofocal acute inflammatory

demyelination (MAID): a unique disorder simulating brain neoplasm. South Med J. 2002; 95:1180–1186.

Hurst, E. W. Acute haemorrhagic leucoencephalitis: a previously undefined entity. Med J Aust. 1941;

2:1–6.

Leake, J. A., Billman, G. F., Nespeca, M. P., Duthie, S. E., Dory, C. E., Meltzer, H. S., et al. Pediatric

acute hemorrhagic leukoencephalitis: report of a surviving patient and review. Clin Infect Dis. 2002; 34:699–703.

Neuromielite Óptica

Matà, S., Lolli, F. Neuromyelitis optica: an update. J Neurol Sci. 2011; 303:13–21.

Outras Síndromes Neuroimunológica

Darnell, R. B., Posner, J. B. Paraneoplastic syndromes. Oxford: Oxford University Press; 2011. Lachance, D. H., Lennon, V. A. Paraneoplastic neurological autoimmunity. In: Kalman B.,

Brannagan T., III., eds. Neuroimmunology in clinical practice. London: Blackwell Publishing Ltd; 2008:210–217.

Lachance, D. H., Lennon, V. A., Pittock, S. J., Tracy, J. A., Krecke, K. N., Amrami, K. K., et al. An

outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study. Lancet Neurol. 2010; 9:55–66.

McKeon, A., Pittock, S. J. Paraneoplastic encephalomyelopathies: pathology and mechanisms. Acta

Neuropathol. 2011; 122:381–400.

Pittock, S. J., Kryzer, T. J., Lennon, V. A. Paraneoplastic antibodies coexist and predict cancer, not

neurological syndrome. Ann Neurol. 2004; 56(5):715–719.

Vincent, A., Bien, C. G., Irani, S. R., Waters, P. Autoantibodies associated with diseases of the CNS:

new developments and future challenges. Lancet Neurol. 2011; 10(8):759–772.

Síndrome do Homem Rígido

Burns, T. M., Jones, H. R., Jr., Phillips 2nd, L. H., Bugawan, T. L., Erlich, H. A., Lennon, V. A. Two

generations of clinically disparate stiff man syndrome confirmed by significant elevations of GAD65 autoantibodies. Neurology. 2003; 61:1291–1293.

Mas, N., Saiz, A., Leite, M. I., Waters, P., Baron, M., Castaño, D., et al. Antiglycine-receptor

encephalomyelitis with rigidity. Neurol Neurosurg Psychiatry. 2011; 82:1399–1401.

McKeon, A., Robinson, M. T., McEvoy, K., Matsumoto, J. Y., Lennon, V. A., Ahlskog, J. E., et al.

Stiff-man syndrome and variants. Arch Neurol. 2012; 69:230–239.

Moersch, F. P., Woltman, H. W. Progressive fluctuating muscular rigidity and spasm (“stiff-man”

syndrome): report of a case and some observations in 13 other cases. Mayo Clin Proc. 1956; 31:421–427.

 

Seção 11 - Infecções do Sistema Nervoso

Aminoff M.J., ed. Neurology and general medicine, 4th ed., Philadelphia: Elsevier, 2008. Del Brutto, O. H., Roos, K. L., Coffey, C. S., Garcia, H. H. Meta-analysis: cysticidal drugs for

neurocysticercosis: albendazole and praziquantel. Ann Intern Med. 2006; 145:43–51.

Halperin, J. J. Nervous system Lyme disease: is there still a controversy? Semin Neurol. 2011;

31:317–324.

Portegies, P., Berger, J.R., eds. HIV/AIDS and the nervous system. Handbook of clinical neurology;

85. Elsevier, Amsterdam, 2007.

Roos, K. L. Principles of neurologic infectious diseases. New York: McGraw-Hill; 2005. Roos, K.L., Tunkel, A.R., eds. Bacterial infections of the central nervous system. Handbook of

clinical neurology; 96. Elsevier, Amsterdam, 2010.

Thwaites, G. E., Fisher, M., Hemingway, C., British Infection Society. British Society guidelines for

the diagnsosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect. 2009; 59:167–187.

Tunkel, A. R., Glaser, C. A., Bloch, K. C., et al. The management of encephalitis: clinical practice

guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008; 47:303–327.

 

Seção 12 - Neuro-oncologia

Abdel-Wahab, M., Etuk, B., Palermo, J., Shirato, H., Kresl, J., Yapicier, O., et al. Spinal cord

gliomas: a multi-institutional retrospective analysis. Int J Radiat Oncol Biol Phys. 2006; 64:1060– 1071.

Andrews, D. W., Suarez, O., Goldman, H. W., Downes, M. B., Bednarz, G., Corn, B. W., et al.

Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution. Int J Radiat Oncol Biol Phys. 2001; 50:1265–1278.

Brandes, A. A., Franceschi, E., Tosoni, A., Blatt, V., Pession, A., Tallini, G., et al. MGMT promoter

methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol. 2008; 26:2192–2197.

Brandsma, D., Stalpers, L., Taal, W., Sminia, P., van den Bent, M. J. Clinical features, mechanisms,

and management of pseudoprogression in malignant gliomas. Lancet Oncol. 2008; 9:453–461.

Bunin, G. R., Surawicz, T. S., Witman, P. A., Larson, D. A. The descriptive epidemiology of

craniopharyngioma. J Neurosurg. 1998; 89:547–551.

CBTRUS. CBTRUS Statistical Report: primary brain and central nervous system tumors diagnosed

in the United States in 2004-6. Hinsdale, IL: Central Brain Tumor Registry of the United States; 2010.

Cho, Y. J., Tsherniak, A., Tamayo, P., Santagata, S., Ligon, A., Greulich, H., et al. Integrative

genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol. 2011; 29:1424–1430.

Colao, A., Cerbone, G., Cappabianca, P., Ferone, D., Alfieri, A., Di Salle, F., et al. Effect of surgery

and radiotherapy on visual and endocrine function in nonfunctioning pituitary adenomas. J Endocrinol Invest. 1998; 21:284–290.

Cueva, R. A. Auditory brainstem response versus magnetic resonance imaging for the evaluation of

asymmetric sensorineural hearing loss. Laryngoscope. 2004; 114:1686–1692.

DeAngelis, L. M., Mandell, L. R., Thaler, H. T., Kimmel, D. W., Galicich, J. H., Fuks, Z., et al. The

role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery. 1989; 24:798–805.

Donahue, B., Steinfeld, A. Intracranial ependymoma in the adult patient: successful treatment with

surgery and radiotherapy. J Neurooncol. 1998; 37:131–133.

Ferrara, N., Kerbel, R. S. Angiogenesis as a therapeutic target. Nature. 2005; 438:967–974.

Friedman, H. S., Prados, M. D., Wen, P. Y., Mikkelsen, T., Schiff, D., Abrey, L. E., et al.

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 2009; 27:4733–4740.

Goldsmith, B. J., Wara, W. M., Wilson, C. B., Larson, D. A. Postoperative irradiation for subtotally

resected meningiomas: a retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg. 1994; 80:195–201.

Kalkanis, S. N., Kondziolka, D., Gaspar, L. E., Burri, S. H., Asher, A. L., Cobbs, C. S., et al. The role

of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010; 96:33–43.

Kocher, M., Soffietti, R., Abacioglu, U., Villà, S., Fauchon, F., Baumert, B. G., et al. Adjuvant

whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol. 2011; 29:134– 141.

Korah, M. P., Nowlan, A. W., Johnstone, P. A., Crocker, I. R. Radiation therapy alone for imaging-

defined meningiomas. Int J Radiat Oncol Biol Phys. 2010; 76:181–186.

Kreisl, T. N., Kim, L., Moore, K., Duic, P., Royce, C., Stroud, I., et al. Phase II trial of single-agent

bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol. 2009; 27:740–745.

Lacroix, M., Abi-Said, D., Fourney, D. R., Gokaslan, Z. L., Shi, W., DeMonte, F., et al. A

multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001; 95:190–198.

Laws, E. R., Jane, J. A., Jr. Pituitary tumors: long-term outcomes and expectations. Clin Neurosurg.

2001; 48:306–319.

Leksell, L. Stereotactic radiosurgery. J Neurol Neurosurg Psychiatry. 1983; 46:797–803. Louis D.N., Ohgaki H., Wiestler O.D., Cavenne W.K., eds. WHO classification of tumours of the

nervous system. Lyon, France: IARC Press, 2007.

Lunsford, L. D., Niranjan, A., Flickinger, J. C., Maitz, A., Kondziolka, D. Radiosurgery of vestibular

schwannomas: summary of experience in 829 cases. J Neurosurg. 2005; 102(Suppl):195–199.

Maranzano, E., Bellavita, R., Rossi, R., De Angelis, V., Frattegiani, A., Bagnoli, R., et al. Short-

course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase

III, randomized, multicenter trial. J Clin Oncol. 2005; 23:3358–3365.

Matthies, C., Samii, M. Management of 1000 vestibular schwannomas (acoustic neuromas): clinical

presentation. Neurosurgery. 1997; 40:1–9. [discussion 9-10].

McLaughlin, M. P., Marcus, R. B., Jr., Buatti, J. M., McCollough, W. M., Mickle, J. P., Kedar, A., et

al. Ependymoma: results, prognostic factors and treatment recommendations. Int J Radiat Oncol Biol Phys. 1998; 40:845–850.

Mendenhall, W. M., Morris, C. G., Amdur, R. J., Foote, K. D., Friedman, W. A. Radiotherapy alone

or after subtotal resection for benign skull base meningiomas. Cancer. 2003; 98:1473–1482.

Minehan, K. J., Brown, P. D., Scheithauer, B. W., Krauss, W. E., Wright, M. P. Prognosis and

treatment of spinal cord astrocytoma. Int J Radiat Oncol Biol Phys. 2009; 73:727–733.

Northcott, P. A., Korshunov, A., Witt, H., Hielscher, T., Eberhart, C. G., Mack, S., et al.

Medulloblastoma comprises four distinct molecular variants. J Clin Oncol. 2011; 29:1408–1414.

Patchell, R. A., Tibbs, P. A., Regine, W. F., Dempsey, R. J., Mohiuddin, M., Kryscio, R. J., et al.

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998; 280:1485–1489.

Patchell, R. A., Tibbs, P. A., Regine, W. F., Payne, R., Saris, S., Kryscio, R. J., et al. Direct

decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005; 366:643–648.

Pomeroy, S. L., Tamayo, P., Gaasenbeek, M., Sturla, L. M., Angelo, M., McLaughlin, M. E., et al.

Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 2002; 415:436–442.

Sgouros, S., Malluci, C. L., Jackowski, A. Spinal ependymomas: the value of postoperative

radiotherapy for residual disease control. Br J Neurosurg. 1996; 10:559–566.

Sherman, J. H., Hoes, K., Marcus, J., Komotar, R. J., Brennan, C. W., Gutin, P. H. Neurosurgery for

brain tumors: update on recent technical advances. Curr Neurol Neurosci Rep. 2011; 11:313–319.

Simpson, D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg

Psychiatry. 1957; 20:22–39.

Smith, J. S., Perry, A., Borell, T. J., Lee, H. K., O’Fallon, J., Hosek, S. M., et al. Alterations of

chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol. 2000; 18:636–645.

Soyuer, S., Chang, E. L., Selek, U., Shi, W., Maor, M. H., DeMonte, F. Radiotherapy after surgery for

benign cerebral meningioma. Radiother Oncol. 2004; 71:85–90.

Stafford, S. L., Perry, A., Suman, V. J., Meyer, F. B., Scheithauer, B. W., Lohse, C. M., et al.

Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc. 1998; 73:936–942.

Stieber, V. W., Mehta, M. P. Advances in radiation therapy for brain tumors. Neurol Clin. 2007;

25:1005–1033. [ix].

Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., et al. Effects of

radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009; 10:459–466.

Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J., et al.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352:987–996.

van den Bent, M. J., Carpentier, A. F., Brandes, A. A., Sanson, M., Taphoorn, M. J., Bernsen, H. H.,

et al. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol. 2006; 24:2715–2722.

Van Meir, E. G., Hadjipanayis, C. G., Norden, A. D., Shu, H. K., Wen, P. Y., Olson, J. J. Exciting

new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin. 2010; 60:166–193.

Vredenburgh, J. J., Desjardins, A., Herndon 2nd, J. E., Dowell, J. M., Reardon, D. A., Quinn, J. A., et

al. Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res. 2007; 13:1253–1259.

Wen, P. Y., Kesari, S. Malignant gliomas in adults. N Engl J Med. 2008; 359:492–507.

Whitaker, S. J., Bessell, E. M., Ashley, S. E., Bloom, H. J., Bell, B. A., Brada, M. Postoperative

radiotherapy in the management of spinal cord ependymoma. J Neurosurg. 1991; 74:720–728.

White, D. R., Sonnenburg, R. E., Ewend, M. G., Senior, B. A. Safety of minimally invasive pituitary

surgery (MIPS) compared with a traditional approach. Laryngoscope. 2004; 114:1945–1948.

 

Seção 13 - Cefaleias

Brenner, M., Oakley, C., Lewis, D. W. Unusual headache syndromes in children. Curr Pain

Headache Rep. 2007; 11:383–389.

Dodick, D. W., Turkel, C. C., DeGryse, R. E., Aurora, S. K., Silberstein, S. D., Lipton, R. B., et al.

OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010; 50:921–936.

Francis, G. J., Becker, W. J., Pringsheim, T. M. Acute and preventive pharmacologic treatment of

cluster headache. Neurology. 2010; 75:463–473.

Goadsby, P. J., Lipton, R. B., Ferrari, M. D. Migraine: current understanding and treatment. N Engl J

Med. 2002; 346:257–270.

Hadjikhani, N., Sanchez Del Rio, M., Wu, O., Schwartz, D., Bakker, D., Fischl, B., et al.

Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001; 98:4687–4692.

Halker, R. B., Hastriter, E. V., Dodick, D. W. Chronic daily headache: an evidence-based and

systematic approach to a challenging problem. Neurology. 2011; 76:S37–S43.

Headache Classification Subcommittee of the International Headache Society. The international

classification of headache disorders: 2nd edition. Cephalalgia. 2004; 24(Suppl 1):9–160.

Lipton, R. B., Bigal, M. E., Diamond, M., Freitag, F., Reed, M. L., Stewart, W. F. Migraine

prevalence, disease burden, and the need for preventive therapy. Neurology. 2007; 68:343–349.

Loder, E., Rizzoli, P. Tension-type headache. BMJ. 2008; 336:88–92.

Matharu, M. S., Schwedt, T. J., Dodick, D. W. Thunderclap headache: an approach to a neurologic

emergency. Curr Neurol Neurosci Rep. 2007; 7:101–109.

Pascual, J., Gonzalez-Mandly, A., Oterino, A., Martin, R. Primary cough headache, primary

exertional headache, and primary headache associated with sexual activity. Handbook Clin Neurol. 2010; 97:459–468.

Robertson, C. E., Black, D. F., Swanson, J. W. Management of migraine headache in the emergency

department. Semin Neurol. 2010; 30:201–211.

Schievink, W. I. Spontaneous spinal cerebrospinal fluid leaks and intracranial hypotension. JAMA.

2006; 295:2286–2296.

Silberstein S.D., Lipton R.B., Dodick D.W., eds. Wolff's headache and other head pain, 8th ed.,

Oxford, England: Oxford University Press, 2001.

Tfelt-Hansen, P. C. History of migraine with aura and cortical spreading depression from 1941 and

onwards. Cephalalgia. 2010; 30:780–792.

 

Seção 14 - Trauma Cefálico

Badjatia, N., Carney, N., Crocco, T. J., Fallat, M. E., Hennes, H. M., Jagoda, A. S., et al. Brain

Trauma Foundation; BTF Center for Guidelines Management. Guidelines for prehospital management of traumatic brain injury 2nd ed. Prehosp Emerg Care. 2008; 12(Suppl 1):S1–S52.

Brain Trauma Foundation. Guidelines for the management of severe traumatic brain injury, 3rd ed. J

Trauma. 24(Suppl 1), 2007.

Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of

Neurological Surgeons; Joint Section on Neurotrauma and Critical Care, AANS/CNS, Bratton SL, Chesnut RM, Ghajar J, McConnell Hammond FF, Harris OA, Hartl R, et al. Guidelines for the management of severe traumatic brain injury. XV. Steroids. J Neurotrauma 2007;24 Suppl 1:S91-5.

Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of

Neurological Surgeons; Joint Section on Neurotrauma and Critical Care, AANS/CNS, Bratton SL, Chestnut RM, Ghajar J, McConnell Hammond FF, Harris OA, Hartl R, et al. Guidelines for the management of severe traumatic brain injury. XIV. Hyperventilation. J Neurotrauma 2007; 24(Suppl 1):S87-90.

Bullock, M. R., Chesnut, R., Ghajar, J., Gordon, D., Hartl, R., Newell, D. W., et al. Surgical

Management of Traumatic Brain Injury Author Group. Surgical management of acute subdural hematomas. Neurosurgery. 2006; 58(Suppl):S16–S24.

Bullock, M. R., Chesnut, R., Ghajar, J., Gordon, D., Hartl, R., Newell, D. W., et al. Surgical

Management of Traumatic Brain Injury Author Group. Surgical management of acute epidural hematomas. Neurosurgery. 2006; 58(Suppl):S7–S15.

Bullock, M. R., Chesnut, R., Ghajar, J., Gordon, D., Hartl, R., Newell, D. W., et al. Surgical

Management of Traumatic Brain Injury Author Group. Surgical management of traumatic parenchymal lesions. Neurosurgery. 2006; 58(Suppl):S25–S46.

Bullock, M. R., Chesnut, R., Ghajar, J., Gordon, D., Hartl, R., Newell, D. W., et al. Surgical

Management of Traumatic Brain Injury Author Group. Surgical management of depressed cranial fractures. Neurosurgery. 2006; 58(Suppl):S56–S60.

Gabriel, E. J., Ghajar, J., Jagoda, A., Pons, P. T., Scalea, T., Walters, B. C. Brain Trauma Foundation.

Guidelines for prehospital management of traumatic brain injury. J Neurotrauma. 2002; 19:111– 174.

Mangat, H. S. Severe traumatic brain injury. Continuum (Minneapolis, Minn). 2012; 18:532–546. Marion, D. W. Evidenced-based guidelines for traumatic brain injuries. Prog Neurol Surg. 2006;

19:171–196.

McIntosh, T. K., Juhler, M., Ragupathi, R., Saatman, K. E., Smith, D. H. Secondary brain injury:

neurochemical and cellular mediators. In: Marion D.W., ed. Traumatic brain injury. New York: Thieme, 1999.

 

OceanofPDF.com